QTREX Quantum Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About QTREX Quantum
Surgical & Medical Instruments & Apparatus, SIC 3841
Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company that develops, manufactures, and commercializes proprietary life-support technologies. Its development efforts target acute respiratory failure solutions designed to offer alternatives or complementary options to traditional mechanical ventilation by enabling spontaneous breathing and reducing the need for invasive intubation or medically induced comas. The company's pipeline includes the flagship INSPIRA ART platform for extracorporeal blood oxygenation and monitoring, the FDA-cleared INSPIRA ART100 cardiopulmonary bypass system for surgical procedures, and the HYLA blood sensor for continuous real-time blood parameter analysis. The company targets healthcare providers across intensive care units, general medical units, operating theaters, and emergency settings.
The company operates its corporate headquarters and principal executive offices in Ra'anana, Israel. Its commercial reach and clinical collaborations include agreements with distributors and deployments to medical centers, such as Westchester Medical Center in New York. Inspira Technologies focuses its deployment strategy across regional health centers, intensive care units, and small urban and rural hospitals.
Summary of the business section of QTREX Quantum's latest annual report, written by StockData.
Company profile
Company
- Legal name
- QTREX Quantum Ltd.
- Founded
- 2018
- Headquarters
- Ra'Anana, Israel
- Address
- Hatidhar 2, 11th Floor
- Phone
- 972-9-9664488
- Website
- inspira-technologies.com
- Employees
- 30, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- Ziv Haft, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- QTEX
- Exchange
- Nasdaq
- IPO date
- Jul 15, 2021
- Shares outstanding
- 36M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- SEC CIK
- 1837493
- CUSIP
- M53637100
- ISIN
- USM536371000
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Dagi Shahar Ben-Noon | Chief Executive Officer, Director | 3,646,133 |
| abraham shabtay | COO | 1,882,713 |
| Yafit Tehila | Chief Financial Officer | 1,420,000 |
| Hayon Daniella Yechezkely | Chief Technology Officer | 1,330,000 |
| Yoav Rozanovich | Chief Business Officer | 550,000 |
| Sivan Matza | Director | 130,000 |
| Tal Parnes | Director | 760,000 |
| Lior Amit | Director | 231,667 |
| Shlomit Chappel-Ram | Director | – |
Employees
Headcount reported in annual reports
“of 30 people as of December 31, 2025.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 15, 2026 | Delisting | Notice of delisting from exchange (Form 25) |
| May 19, 2026 | Name change | Name changed from Inspira Technologies OXY B.H.N. Ltd to QTREX Quantum Ltd. |
| Jul 15, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 30, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |